Signaturefd, LLC Organon & Co. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Organon & Co. stock. As of the latest transaction made, Signaturefd, LLC holds 10,814 shares of OGN stock, worth $159,290. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,814

Previous 11,308 4.37%

Holding current value

$159,290

Previous $234,000 11.97%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$18.65 - $23.03 $9,213 - $11,376	-494 Reduced 4.37%	10,814 $206,000
Q2 2024 Jul 29, 2024	BUY	$17.45 - $21.96 $12,180 - $15,328	698 Added 6.58%	11,308 $234,000
Q1 2024 May 03, 2024	BUY	$13.78 - $18.8 $19,567 - $26,696	1,420 Added 15.45%	10,610 $199,000
Q4 2023 Jan 31, 2024	BUY	$10.95 - $17.32 $81,895 - $129,536	7,479 Added 437.11%	9,190 $132,000
Q3 2023 Nov 03, 2023	SELL	$16.59 - $23.77 $1,941 - $2,781	-117 Reduced 6.4%	1,711 $29,000
Q2 2023 Aug 01, 2023	SELL	$19.27 - $24.63 $29,637 - $37,880	-1,538 Reduced 45.69%	1,828 $38,000
Q1 2023 Apr 28, 2023	BUY	$21.42 - $32.08 $4,562 - $6,833	213 Added 6.76%	3,366 $79,000
Q4 2022 Jan 27, 2023	BUY	$23.31 - $28.61 $12,074 - $14,819	518 Added 19.66%	3,153 $88,000
Q3 2022 Nov 08, 2022	SELL	$23.4 - $34.25 $103,334 - $151,248	-4,416 Reduced 62.63%	2,635 $62,000
Q2 2022 Aug 10, 2022	SELL	$31.66 - $38.9 $73,356 - $90,131	-2,317 Reduced 24.73%	7,051 $238,000
Q1 2022 May 02, 2022	SELL	$30.45 - $39.36 $5,389 - $6,966	-177 Reduced 1.85%	9,368 $327,000
Q4 2021 Jan 25, 2022	SELL	$28.67 - $37.13 $21,645 - $28,033	-755 Reduced 7.33%	9,545 $291,000
Q3 2021 Oct 28, 2021	BUY	$28.63 - $35.64 $216,414 - $269,402	7,559 Added 275.78%	10,300 $338,000
Q2 2021 Jul 26, 2021	BUY	$28.45 - $38.0 $77,981 - $104,158	2,741 New	2,741 $83,000

Others Institutions Holding OGN

# of Institutions

791

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account